BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31219420)

  • 1. [Activation of coagulation in patients with lung cancer].
    Hammouda A; Souilah S; Ferhat-Hamida MY; Amir ZC; Aouichat-Bouguerra S; Hariti G
    Ann Biol Clin (Paris); 2019 Jun; 77(3):272-280. PubMed ID: 31219420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between increased granulocyte elastase release and activation of blood coagulation in patients with lung cancer.
    Gabazza E; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
    Cancer; 1993 Oct; 72(7):2134-40. PubMed ID: 7690680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
    Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
    Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of plasma D-dimer levels in lung carcinoma.
    Komurcuoglu B; Ulusoy S; Gayaf M; Guler A; Ozden E
    Tumori; 2011; 97(6):743-8. PubMed ID: 22322841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and prognostic significance of coagulation assays in lung cancer.
    Tas F; Kilic L; Serilmez M; Keskin S; Sen F; Duranyildiz D
    Respir Med; 2013 Mar; 107(3):451-7. PubMed ID: 23200643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research on the coagulation function changes in non small cell lung cancer patients and analysis of their correlation with metastasis and survival.
    Qi Y; Fu J
    J BUON; 2017; 22(2):462-467. PubMed ID: 28534370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon.
    Wojtukiewicz MZ; Zacharski LR; Moritz TE; Hur K; Edwards RL; Rickles FR
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):429-37. PubMed ID: 1330024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of blood coagulation tests in lung cancer.
    Ferrigno D; Buccheri G; Ricca I
    Eur Respir J; 2001 Apr; 17(4):667-73. PubMed ID: 11401062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic value of D-dimer in lung cancer.
    İnal T; Anar C; Polat G; Ünsal İ; Halilçolar H
    Clin Respir J; 2015 Jul; 9(3):305-13. PubMed ID: 24720709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study.
    Hou C; Jiang F; Ma H; Zhu Q; Wang Z; Zhao B; Xue T; Tan S; Yang R; Qian Y; Luo X; Zhao M; Xu X; Chen L; Li J
    Thorac Cancer; 2019 Feb; 10(2):304-311. PubMed ID: 30609303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism.
    Sun W; Ren H; Gao CT; Ma WD; Luo L; Liu Y; Jin P; Hao JH
    Am J Clin Oncol; 2015 Dec; 38(6):550-6. PubMed ID: 24401666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated-protein-C resistance in cancer patients.
    Green D; Maliekel K; Sushko E; Akhtar R; Soff GA
    Haemostasis; 1997; 27(3):112-8. PubMed ID: 9306127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis.
    Seitz R; Rappe N; Kraus M; Immel A; Wolf M; Maasberg M; Egbring R; Pfab R; Havemann K
    Blood Coagul Fibrinolysis; 1993 Apr; 4(2):249-54. PubMed ID: 8388741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
    Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
    Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
    Alevizopoulos A; Tyritzis S; Leotsakos I; Anastasopoulou I; Pournaras C; Kotsis P; Katsarou O; Alamanis C; Stravodimos K; Constantinides C
    Int J Urol; 2017 Feb; 24(2):130-136. PubMed ID: 28004432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changes of blood coagulation in surgical patients with lung cancer].
    Xu C; Fu X
    Zhongguo Fei Ai Za Zhi; 2010 Feb; 13(2):136-9. PubMed ID: 20673507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Mo D; He F
    Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemostatic abnormalities in lung cancer: prognostic implications.
    Buccheri G; Ferrigno D; Ginardi C; Zuliani C
    Eur J Cancer; 1997 Jan; 33(1):50-5. PubMed ID: 9071899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.